Continuing education and professional development: Unifying opportunities for genetic counselors globally
- PMID: 39712969
- PMCID: PMC11658550
- DOI: 10.1016/j.gimo.2024.101854
Continuing education and professional development: Unifying opportunities for genetic counselors globally
Keywords: Continuing education; Continuing professional development; Genetic counseling; Online asynchronous courses.
Conflict of interest statement
Daniel J. Rader is a member of the scientific advisory boards of Alnylam Pharmaceuticals, Novartis, and Verve Therapeutics. Elizabeth M. McNally is or was a consultant for Amgen, Cytokinetics, PepGen, and Tenaya Therapeutics, and she is a founder of Ikaika Therapeutics. Debra Duquette is a member of the genetic testing/laboratory panel advisory group for Carelon. These activities are unrelated to the content of this work. All other authors declare no conflicts of interest.
References
-
- Paneque M., Shea O., Narravula A., et al. Thirty-years of genetic counselling education in Europe: a growing professional area. Eur J Hum Genet. Published online February 15, 2024 doi: 10.1038/s41431-024-01552-8. [published correction appears in Eur J Hum Genet. Published online March 11, 2024]. - DOI - PMC - PubMed
-
- Transnational Alliance for Genetic Counseling. University of South Carolina, School of Medicine Columbia. https://sc.edu/study/colleges_schools/medicine/centers_and_institutes_ne...
LinkOut - more resources
Full Text Sources
